Gastroesophageal Junction Carcinoma (GEJC)
1 clinical trials · Condition
◉ Watch Gastroesophageal Junction Carcinoma (GEJC)
| Record | Firm | Date |
|---|---|---|
| Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) (NCT04210115) | Merck Sharp & Dohme LLC | 2020-02-28 |
Track Gastroesophageal Junction Carcinoma (GEJC) automatically
Every clearance here is in the API, with alerts when new ones post.